Abstract:Abstract Over the past two decades, China has become a distinctive and increasingly important donor of development assistance for health (DAH). However, little is known about what factors influence China’s priority-setting for DAH. In this study, we provide an updated analysis of trends in the priorities of Chinese DAH and compare them to comparable trends among OECD Development Assistance Committee (DAC) donors using data from the AidData’s Global Chinese Development Finance Dataset (2000–2017, version 2.0) and the Creditor Reporting System (CRS) database (2000–2017). We also analyse Chinese medical aid exports before and after the start of the COVID-19 pandemic using a Chinese Aid Exports Database. We further explore the potential factors influencing China’s shifting priority-setting processes by reviewing Chinese official documents following Walt and Gilson’s policy analysis framework (context–actors–process–content) and by testing our conjectures empirically. We find that China has become an important DAH donor to most regions if measured using project value, including but not limited to Africa. China has prioritized aid to African and Asian countries as well as to CRS subsectors that are not prioritized by DAC donors, such as medical services and basic health infrastructure. Chinese quarterly medical aid exports almost quintupled after the start of the COVID-19 pandemic. Noticeably, China has allocated more attention to Asia, eye diseases and infectious disease outbreaks over time. In contrast, the priority given to malaria has declined over the same period. Regarding factors affecting priority shifts, the outbreaks of SARS and Ebola, the launch of the Belt and Road Initiative and the COVID-19 pandemic appear to be important milestones in the timeline of Chinese DAH. Unlike stereotypes of China as a ‘lone wolf’ donor, our analysis suggests multilateral processes are influential in informing and setting Chinese DAH priorities.

Mask Diplomacy? Understanding China's Goals in Delivering Medical Aid in the First Wave of the COVID-19 Pandemic

Mask Wars: China's Exports of Medical Goods in Times of COVID-19

Mining and quantitative evaluation of COVID-19 policy tools in China

Characterizing the Patterns of China's Policies Against COVID-19: A Bibliometric Study.

Understanding China’s shifting priorities and priority-setting processes in development assistance for health

Mask Crisis During the COVID-19 Outbreak

The Mask Diplomacy of China in Southeast Asia

The political economy of vaccine distribution and China's Belt and Road Initiative

CHINA’S GROWING INVOLVEMENT IN GLOBAL HEALTH GOVERNANCE

COVID-19 and China’s Changing Soft Power in Italy

Chinese Crisis Communication in the Early Stage of the COVID-19 Pandemic: A Discourse Analysis of People's Daily News Articles in Response to Threatening International News Coverage

Twitter Diplomacy and China's Strategic Narrative during the Early COVID-19 Crisis

The Application of Mask Diplomacy: China’s Belt and Road Initiative as Health Diplomacy in Middle East and North Africa (MENA) Countries During COVID-19

Achieving Universal Wearing of Face Masks During the COVID-19 Pandemic: A Practical Solution from Shanghai, China

Vaccine diplomacy: nation branding and China’s COVID-19 soft power play

China's distinctive engagement in global health.

Coordinated Management of COVID-19 Response: Lessons From Whole-of-Society and Whole-of-Health Strategies in Wuhan, China

For the Good of the People: an interpretive analysis of Chinese volunteerism in the critical matter of care at the start of the pandemic

Crisis governance, Chinese style: distinctive features of China’s response to the Covid-19 pandemic

Does It Matter to Establish a Strategic Partnership for COVID-19 Prevention and Control? The Perspective of Multiple Distances in Emerging Economies

China's COVID-19 Control Strategy and Its Impact on the Global Pandemic